RE: Snake venom preparation for drug-resistant human immunodeficiency virus

Annals of Saudi Medicine

Volumn 29, Issue 2, 2009, Pages 159-

  Meenakshisundaram, Ramachandram ^a   Uma, Alagappan ^b   Subramanian, Thirumalaikolundu ^c  

^a MADRAS MEDICAL COLLEGE   (India)

^b MADURAI MEDICAL COLLEGE   (India)

^c The Tamil Nadu Dr MGR Medical University   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; SNAKE VENOM; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL RESISTANCE; CLINICAL PRACTICE; DRUG ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; ADULT; CD4 LYMPHOCYTE COUNT; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; SNAKE VENOMS;

EID: 68949103978     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.4103/0256-4947.51791     Document Type: Letter

References (3)

1. Alrajhi AA, Almohaizeie A. Snake venom preparation for drug-resistant human immunodeficiency virus. Ann Saudi Med 2008;28(4):292-293.
2. Neri P, Bracci L, Rustici M, Santucci A. Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Archives of Virology 1990; 114(3-4): 265-269.
3. Simon CW, Philippe F, Olivier C, Gavin DL, Mark CW, Rebecca LM, Reto S, Robert AH, Molecular characterization of endogenous snake venom metalloproteinase inhibitors. Biochemical and biophysical research communications 2008; 365(4):650-656.